Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast

Author(s): Barth PJ, Moll R, Ramaswamy A

Abstract

In the present study, we analyzed tumor associated stromal remodeling with special respect to SPARC (secreted protein acid rich in cysteine) expression. 25 invasive ductal carcinomas of the breast and corresponding tumor-free breast tissue were studied immunohistochemically (CD34, alpha-SMA, SPARC and TGFbeta-R1). Tumor associated stroma was characterized by a loss of CD34 expression, paralleled by a gain in alpha-SMA. While SPARC expression was virtually absent from normal stromal cells in the tumor stroma, strong cytoplasmic SPARC reactivity was found in the majority of stromal cells. The TGFbeta-R1 also showed stronger expression in the tumor stroma compared to that of the normal breast. Stromal response to antecedent core needle biopsy was similar to that observed in the tumor stroma. We conclude that SPARC overexpression is a constant and functionally important feature of invasive ductal carcinomas, since SPARC mediates stromal de-adhesion crucial for local tumor invasion and systemic spread, respectively. When considering changes of the stromal phenotype (normal: CD34+alpha-SMA-SPARC- vs. carcinoma: CD34-alpha-SMA+SPARC+) as a tool in distinguishing benign from malignant breast lesion one has to keep in mind that the phenotype of granulation tissue in areas of antecedent biopsy resembles that of tumor stroma.

Similar Articles

Osteonectin, a bone-specific protein linking mineral to collagen

Author(s): Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, et al.

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma

Author(s): Mantoni TS, Schendel RR, Rödel F, Niedobitek G, Al-Assar O, et al.

Frequent inactivation of SPARC by promoter hypermethylation in colon cancers

Author(s): Yang E, Kang HJ, Koh KH, Rhee H, Kim NK, et al.

Fibroblasts in cancer

Author(s): Kalluri R, Zeisberg M

CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions

Author(s): Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A